Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Carotid and Renal Artery Stents are expandable tubes inserted into narrowed arteries to improve blood flow. GlobalData uses proprietary data and analytics to provide a comprehensive report on the carotid and renal artery stents market in New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the carotid and renal artery stents market in New Zealand was Abbott Laboratories followed by Cordis, Boston Scientific, Terumo, Cook Medical, Biotronik SE and Medtronic.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Carotid arteries become narrowed due to plaque formation and buildup in the inner surface of the arteries. Carotid stenosis is further classified into two indications: symptomatic and asymptomatic carotid stenosis. Patients with symptomatic carotid stenosis may present with symptoms such as transient ischemic attacks or temporary vision loss, whereas asymptomatic carotid stenosis is not associated with such symptoms. Carotid artery stenosis is a major contributor to ischemic stroke. Renal Artery Stents are expandable tubes implanted to improve blood flow in the narrowed renal artery. Renal arteries can become narrowed due to plaque formation in the inner surface of the arteries. A Carotid Artery Bare Metal Stent is a metal-mesh tube implanted to improve blood flow in a narrowed carotid artery. A Renal Artery Bare Metal Stent is a metal-mesh tube implanted to improve blood flow in a narrowed renal artery. The Transcarotid Stent System is a nitinol self- expanding stent that is implanted to form a lattice that covers the narrowed carotid artery and pushes outward on luminal surface, helping to maintain the carotid artery.
The carotid and renal artery stents market in New Zealand can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size carotid and renal artery stents in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
